Evercore ISI’s Julian Emanuel thinks Nvidia’s monster rally is fueling a fear of missing out in the market. He finds clients, including many who traded through the dot-com boom and subsequent collapse, are more worried about being underinvested than overexposed right now. “That’s the first time that’s happened since 2021 for us,” the firm’s senior … Read more
A preliminary review of side effects from popular drugs used to treat diabetes and obesity shows no link with suicidal thoughts or actions, the U.S. Food and Drug Administration said Thursday. But the agency also said officials cannot definitively rule out that “a small risk may exist” and that they’ll continue to look into reports … Read more
As the winter blues set in for many in Canada, experts say feelings of depression can lead people to gain weight, with new research suggesting that the risk of weight increases in the short term are higher in people who are already obese. A study by University of Cambridge scientists published in the PLOS ONE … Read more
Eli Lilly has launched a unique website to connect U.S. patients seeking obesity treatment to doctors, dieticians and its new weight-loss drug, Zepbound. The drugmaker said Thursday it will use the site, called LillyDirect, to pair visitors with third-party mail-order pharmacies for prescriptions and to care providers through a virtual medical weight-loss clinic. The site … Read more
WASHINGTON — New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out of reach for millions of older Americans because Medicare is forbidden to cover such medications. Drugmakers and a wide-ranging and growing bipartisan coalition of lawmakers are gearing up to push for that to change … Read more
